Albumin ameliorates tissue plasminogen activator-mediated blood-brain barrier permeability and ischemic brain injury in rats

Neurological Research

Volumn 31, Issue 2, 2009, Pages 189-194

  Tang, Jin ^a   Li, Ya Jun ^a   Mu, Jun ^a   Li, Qi ^a   Yang, De Yu ^a   Xie, Peng ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Albumin; Blood brain barrier; Embolization; Ischemic brain injury; Perfusion deficits; Tissue plasminogen activator

Indexed keywords

ALTEPLASE; EVANS BLUE; HUMAN SERUM ALBUMIN; SODIUM CHLORIDE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN INFARCTION SIZE; BRAIN INJURY; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFECT; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NEUROLOGIC DISEASE; NONHUMAN; RAT; REPERFUSION;

ALBUMINS; ANALYSIS OF VARIANCE; ANIMALS; BLOOD-BRAIN BARRIER; BRAIN EDEMA; BRAIN INJURIES; CAPILLARY PERMEABILITY; CELL COUNT; CELL DEATH; DISEASE MODELS, ANIMAL; FIBRINOLYTIC AGENTS; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; NEUROLOGIC EXAMINATION; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TETRAZOLIUM SALTS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 62549091955     PISSN: 01616412     EISSN: None     Source Type: Journal    
DOI: 10.1179/174313209X393898     Document Type: Article

References (15)

1. Nagai N, De Mol M, Lijnen HR et al. Role of plasminogen system components in focal cerebral ischemic infarction: A gene targeting and gene transfer study in mice. Circulation 1999; 99: 2440-2444
2. Kahles T, Foerch C, Sitzer M, et al. Tissue plasminogen activator mediated blood-brain barrier damage in transient focal cerebral ischemia in rats: Relevance of interactions between thrombotic material and thrombolytic agent, Vascul Pharmacol 2005; 43: 254-259
3. Benchenane K, Berezowski V, Fernandez-Monreal M, et al. Oxygen glucose deprivation switches the transport of tPA across the blood-brain barrier from an LRP-dependent to an increased LRP-independent process. Stroke 2005; 36: 1065-1070
4. Belayev L, Marcheselli VL, Khoutorova L, et al. Docosahexaenoic acid complexed to albumin elicits high-grade ischemic neuroprotection. Stroke 2005; 36: 118-123
5. Belayev L, Saul I, Busto R, et al. Albumin treatment reduces neurological deficit and protects blood-brain barrier integrity after acute intracortical hematoma in the rat. Stroke 2005; 36: 326-331
6. Belayev L, Liu Y, Zhao W, et al. Human albumin therapy of acute ischemic stroke: Marked neuroprotective efficacy at moderate doses and with a broad therapeutic window. Stroke 2001; 32: 553-560
7. Longa EZ, Weinstein PR, Carlson S, et al. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91
8. Yang DY, Pan HC, Chen C-J, et al. Effects of tissue plasminogen activator on cerebral microvessels of rats during focal cerebral ischemia and reperfusion. Neurol Res 2007; 29: 274-282
9. Kano T, Harada T, Katayama Y. Attenuation of extravasation of tissue plasminogen activator by the free radical scavenger, edaravone: Evaluation in a rat thromboembolic stroke model. Neurol Res 2005; 27: 499-502
10. Rogove AD, Siao C, Keyt B, et al. Activation of microglia reveals a non-proteolytic cytokine function for tissue plasminogen activator in the central nervous system. J Cell Sci 1999; 112: 4007-4016
11. Wang X, Lee SR, Arai K, et al. Lipoprotein receptor-mediated induction of matrix metalloproteinase by tissue plasminogen activator. Nat Med 2003; 9: 1313-1317
12. Zhang W, Sato K, Hayashi T, et al. Extension of ischemic therapeutic time window by a free radical scavenger, Edaravone, reperfused with tPA in rat brain. Neurol Res 2004; 26: 342-348
13. Chen TY, Lee MY, Chen HY, et al. Melatonin attenuates the postischemic increase in blood-brain barrier permeability and decreases hemorrhagic transformation of tissue-plasminogen activator therapy following ischemic stroke in mice. J Pineal Res 2006; 40: 242-250
14. Wayner DD, Burton GW, Ingold KU, et al. Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 1985; 187: 33-37
15. Huh PW, Belayev L, Zhao W, et al. The effect of high-dose albumin therapy on local cerebral perfusion after transient focal cerebral ischemia in rats. Brain Res 1998; 804: 105-113